Thuy, T.T.M., Trang, N.T.H., Vy, T.T., Duc, V.T., Nam, N.H., Chien, P.C., Nhi, L.H.H. and Minh, L.H.N., 2022. Role of diffusion-weighted MRI in differentiation between benign and malignant anterior mediastinal masses. Frontiers in Oncology, p.5475.
Thuy, T.T.M., Trang, N.T.H., Vy, T.T., Duc, V.T., Nam, N.H., Chien, P.C., Nhi, L.H.H. and Minh, L.H.N., 2022. Role of diffusion-weighted MRI in differentiation between benign and malignant anterior mediastinal masses. Frontiers in Oncology, p.5475.
Thuy, T.T.M., Trang, N.T.H., Vy, T.T., Duc, V.T., Nam, N.H., Chien, P.C., Nhi, L.H.H. and Minh, L.H.N., 2022. Role of diffusion-weighted MRI in differentiation between benign and malignant anterior mediastinal masses. Frontiers in Oncology, p.5475.
Thuy, T.T.M., Trang, N.T.H., Vy, T.T., Duc, V.T., Nam, N.H., Chien, P.C., Nhi, L.H.H. and Minh, L.H.N., 2022. Role of diffusion-weighted MRI in differentiation between benign and malignant anterior mediastinal masses. Frontiers in Oncology, p.5475.
Abstract
Background. To describe the characteristics of anterior mediastinal masses on conventional magnetic resonance imaging (MRI) and to assess the role of the Apparent Diffusion Coefficient (ADC) value in distinguishing benign from malignant mediastinal lesions. Methods. We conducted a retrospective cross-sectional study on 55 patients with anterior mediastinal mass who performed MRI before treatment. Biopsy and histopathological assessments were done after that. A radiologist evaluates the changes of signal intensity on these sequences: T1- weighted VIBE DIXON pre and post-contrast with Gadolinium, T2 HASTE, T2 TIRM, DWI/ADC, to determine the size, margin of the lesion, the presence of fat, cystic in it. ADCs values were calculated from the ADC maps which were constructed from b = 0 and b = 2000 Results. The study was composed of 55 patients, with 5 benign lesions and 50 malignant lesions. The ADCmean, ADCmedian, ADC10, and ADC90 in the histogram-based approach and hot-spot-ROI-based mean ADC for the malignant lesions was significantly lower than those found in benign lesions (P-value <0.05). The hot-spot-ROI-based mean ADC had the highest value in differentiation between benign and malignant mediastinal lesions, between group A (benign lesions, thymoma A, AB, B1) and group B (thymoma B2, B3 and other malignant lesions). The cut-off point of the ADC value differentiating malignant from benign mediastinal lesions was 1,17x10-3mm2/s with sensitivity of 80%, and specificity of 80%. The cut off point of the ADC value differentiating group A from group B was 0.99 x10-3mm2/s with sensitivity of 78,4%, and specificity of 88.9%. The cut-off point of the ADC value differentiating lymphoma from other malignant lesions was 0,91 x10-3mm2/s with sensitivity of 100%, and specificity of 60.5%. Conclusion. Diffusion-weighted MRI and measurement of ADC value in histogram-based approach and hot-spot-ROI-based mean ADC are very helpful in the differentiation between benign and malignant anterior mediastinal lesions.
Medicine and Pharmacology, Oncology and Oncogenics
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
